Cover Image
Market Research Report
Product code
1006871

United States Dna Sequencing Market Forecast 2021-2026

Published: | Inkwood Research | 148 Pages | Delivery time: 2-3 business days

Price

Back to Top
United States Dna Sequencing Market Forecast 2021-2026
Published: May 24, 2021
Inkwood Research
Content info: 148 Pages
Delivery time: 2-3 business days
  • ALL
  • Description
  • Table of Contents
Description

KEY FINDINGS

The United States DNA sequencing market is set to register a CAGR of 16.89% during the forecast period, 2021-2026. Technological developments, advanced healthcare infrastructure, and increasing investment in R&D propel market growth in the country.

MARKET INSIGHTS

In the United States, several programs and initiatives facilitate market growth. For instance, the precision medicine initiative cohort program encourages around 1 million participants to enhance their ability to treat and prevent diseases associated with differences in genetics, environment, and lifestyle. Also, universal newborn screening plans are conducted in the country. As per research studies, within 24-48 hours after birth, few blood drops drawn from newborns are sent to labs to screen for life-threatening disorders. Such genome sequence-based diagnostics and government plans are raising market demands in the US.

DNA sequencing has also caused a paradigm shift in proteomic and genomic research. This is attributed to its accuracy and high-throughput technology utilized for varied applications. It is adopted in many academic research institutes. For instance, in June 2020, NovaSeq 6000 Sequencing System was installed by Illumina at the Whitehead Institute for Biomedical Research, Massachusetts. Such factors boost the market growth.

COMPETITIVE INSIGHTS

Some of the market's leading players include PerkinElmer Inc, Illumina Inc, Danaher Corporation (Integrated DNA Technologies Inc), Agilent Technologies Inc, Adaptive Biotechnologies Inc, Bio-Rad Laboratories Inc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 36376

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. COUNTRY SNAPSHOT
  • 2.3. COUNTRY ANALYSIS
  • 2.4. KEY GROWTH ENABLERS
  • 2.5. KEY CHALLENGES

3. KEY ANALYTICS

  • 3.1. IMPACT OF COVID-19 ON DNA SEQUENCING MARKET
  • 3.2. KEY MARKET TRENDS
  • 3.3. PORTER'S FIVE FORCES ANALYSIS
    • 3.3.1. BUYERS POWER
    • 3.3.2. SUPPLIERS POWER
    • 3.3.3. SUBSTITUTION
    • 3.3.4. NEW ENTRY
    • 3.3.5. INDUSTRY RIVALRY
  • 3.4. OPPORTUNITY MATRIX
  • 3.5. VENDOR LANDSCAPE
  • 3.6. VALUE CHAIN ANALYSIS
  • 3.7. KEY BUYING CRITERIA

4. MARKET BY TECHNOLOGY

  • 4.1. SEQUENCING BY SYNTHESIS
  • 4.2. ION SEMICONDUCTOR SEQUENCING
  • 4.3. CHAIN TERMINATION SEQUENCING
  • 4.4. PYROSEQUENCING
  • 4.5. SEQUENCING BY LIGATION (SBL)
  • 4.6. SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT)
  • 4.7. NANOPORE SEQUENCING
  • 4.8. OTHER TECHNOLOGIES

5. MARKET BY APPLICATION

  • 5.1. BIOMARKER DISCOVERY
  • 5.2. DIAGNOSTICS
  • 5.3. REPRODUCTIVE HEALTH
  • 5.4. PERSONALIZED MEDICINE
  • 5.5. DRUG DISCOVERY
  • 5.6. AGRICULTURE & ANIMAL RESEARCH
  • 5.7. FORENSICS
  • 5.8. OTHER APPLICATIONS

6. MARKET BY PRODUCT

  • 6.1. INSTRUMENTS & CONSUMABLES
    • 6.1.1. INSTRUMENTS & CONSUMABLES TYPE
      • 6.1.1.1. CONSUMABLES
      • 6.1.1.2. INSTRUMENTS
    • 6.1.2. INSTRUMENTS & CONSUMABLES PLATFORM
      • 6.1.2.1. NGS (NEXT GENERATION SEQUENCING)
      • 6.1.2.1.1. RNA SEQUENCING
      • 6.1.2.1.2. TARGETED RESEQUENCING
      • 6.1.2.1.3. WHOLE-EXOME SEQUENCING
      • 6.1.2.1.4. WHOLE-GENOME SEQUENCING
      • 6.1.2.1.5. CHIP SEQUENCING
      • 6.1.2.1.6. DE NOVO SEQUENCING
      • 6.1.2.1.7. METHYL SEQUENCING
      • 6.1.2.2. SANGER
  • 6.2. SEQUENCING SERVICES
  • 6.3. BIOINFORMATICS

7. MARKET BY END-USER

  • 7.1. RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
  • 7.2. PHARMACEUTICAL
  • 7.3. BIOTECHNOLOGY COMPANIES
  • 7.4. HOSPITALS & CLINICS
  • 7.5. OTHER END-USERS

8. COMPETITIVE LANDSCAPE

  • 8.1. KEY STRATEGIC DEVELOPMENTS
    • 8.1.1. MERGERS & ACQUISITIONS
    • 8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 8.1.3. PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
    • 8.1.4. BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS
  • 8.2. COMPANY PROFILES
    • 8.2.1. ADAPTIVE BIOTECHNOLOGIES INC
    • 8.2.2. AGILENT TECHNOLOGIES INC
    • 8.2.3. BIO-RAD LABORATORIES INC
    • 8.2.4. DANAHER CORPORATION (INTEGRATED DNA TECHNOLOGIES INC)
    • 8.2.5. ILLUMINA INC
    • 8.2.6. PERKINELMER INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - DNA SEQUENCING
  • TABLE 2: UNITED STATES DNA SEQUENCING MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: UNITED STATES DNA SEQUENCING MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2026 (IN $ MILLION)
  • TABLE 4: UNITED STATES DNA SEQUENCING MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: UNITED STATES DNA SEQUENCING MARKET, BY APPLICATION, FORECAST YEARS, 2021-2026 (IN $ MILLION)
  • TABLE 6: UNITED STATES DNA SEQUENCING MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: UNITED STATES DNA SEQUENCING MARKET, BY PRODUCT, FORECAST YEARS, 2021-2026 (IN $ MILLION)
  • TABLE 8: UNITED STATES INSTRUMENTS & CONSUMABLES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: UNITED STATES INSTRUMENTS & CONSUMABLES MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)
  • TABLE 10: UNITED STATES INSTRUMENTS & CONSUMABLES MARKET, BY PLATFORM, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: UNITED STATES INSTRUMENTS & CONSUMABLES MARKET, BY PLATFORM, FORECAST YEARS, 2021-2026 (IN $ MILLION)
  • TABLE 12: UNITED STATES NGS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 13: UNITED STATES NGS MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)
  • TABLE 14: UNITED STATES DNA SEQUENCING MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 15: UNITED STATES DNA SEQUENCING MARKET, BY END-USER, FORECAST YEARS, 2021-2026 (IN $ MILLION)
  • TABLE 16: LIST OF MERGERS & ACQUISITIONS
  • TABLE 17: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 18: LIST OF PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
  • TABLE 19: LIST OF BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS

LIST OF FIGURES

  • FIGURE 1: LIMITATIONS OF DNA SEQUENCING IN DIAGNOSTIC TESTING
  • FIGURE 2: KEY MARKET TRENDS
  • FIGURE 3: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: UNITED STATES DNA SEQUENCING MARKET, BY TECHNOLOGY, IN 2020
  • FIGURE 7: UNITED STATES DNA SEQUENCING MARKET, BY SEQUENCING BY SYNTHESIS, 2021-2026 (IN $ MILLION)
  • FIGURE 8: UNITED STATES DNA SEQUENCING MARKET, BY ION SEMICONDUCTOR SEQUENCING, 2021-2026 (IN $ MILLION)
  • FIGURE 9: UNITED STATES DNA SEQUENCING MARKET, BY CHAIN TERMINATION SEQUENCING, 2021-2026 (IN $ MILLION)
  • FIGURE 10: UNITED STATES DNA SEQUENCING MARKET, BY PYROSEQUENCING, 2021-2026 (IN $ MILLION)
  • FIGURE 11: UNITED STATES DNA SEQUENCING MARKET, BY SEQUENCING BY LIGATION (SBL), 2021-2026 (IN $ MILLION)
  • FIGURE 12: UNITED STATES DNA SEQUENCING MARKET, BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT), 2021-2026 (IN $ MILLION)
  • FIGURE 13: UNITED STATES DNA SEQUENCING MARKET, BY NANOPORE SEQUENCING, 2021-2026 (IN $ MILLION)
  • FIGURE 14: UNITED STATES DNA SEQUENCING MARKET, BY OTHER TECHNOLOGIES, 2021-2026 (IN $ MILLION)
  • FIGURE 15: UNITED STATES DNA SEQUENCING MARKET, BY APPLICATION, IN 2020
  • FIGURE 16: UNITED STATES DNA SEQUENCING MARKET, BY BIOMARKER DISCOVERY, 2021-2026 (IN $ MILLION)
  • FIGURE 17: UNITED STATES DNA SEQUENCING MARKET, BY DIAGNOSTICS, 2021-2026 (IN $ MILLION)
  • FIGURE 18: UNITED STATES DNA SEQUENCING MARKET, BY REPRODUCTIVE HEALTH, 2021-2026 (IN $ MILLION)
  • FIGURE 19: UNITED STATES DNA SEQUENCING MARKET, BY PERSONALIZED MEDICINE, 2021-2026 (IN $ MILLION)
  • FIGURE 20: UNITED STATES DNA SEQUENCING MARKET, BY DRUG DISCOVERY, 2021-2026 (IN $ MILLION)
  • FIGURE 21: UNITED STATES DNA SEQUENCING MARKET, BY AGRICULTURE & ANIMAL RESEARCH, 2021-2026 (IN $ MILLION)
  • FIGURE 22: UNITED STATES DNA SEQUENCING MARKET, BY FORENSICS, 2021-2026 (IN $ MILLION)
  • FIGURE 23: UNITED STATES DNA SEQUENCING MARKET, BY OTHER APPLICATIONS, 2021-2026 (IN $ MILLION)
  • FIGURE 24: UNITED STATES DNA SEQUENCING MARKET, BY PRODUCT, IN 2020
  • FIGURE 25: UNITED STATES DNA SEQUENCING MARKET, BY INSTRUMENTS & CONSUMABLES, 2021-2026 (IN $ MILLION)
  • FIGURE 26: UNITED STATES INSTRUMENTS & CONSUMABLES MARKET, BY CONSUMABLES, 2021-2026 (IN $ MILLION)
  • FIGURE 27: UNITED STATES INSTRUMENTS & CONSUMABLES MARKET, BY INSTRUMENTS, 2021-2026 (IN $ MILLION)
  • FIGURE 28: UNITED STATES INSTRUMENTS & CONSUMABLES MARKET, BY NGS, 2021-2026 (IN $ MILLION)
  • FIGURE 29: UNITED STATES NGS MARKET, BY RNA SEQUENCING, 2021-2026 (IN $ MILLION)
  • FIGURE 30: UNITED STATES NGS MARKET, BY TARGETED RESEQUENCING, 2021-2026 (IN $ MILLION)
  • FIGURE 31: UNITED STATES NGS MARKET, BY WHOLE-EXOME SEQUENCING, 2021-2026 (IN $ MILLION)
  • FIGURE 32: UNITED STATES NGS MARKET, BY WHOLE-GENOME SEQUENCING, 2021-2026 (IN $ MILLION)
  • FIGURE 33: UNITED STATES NGS MARKET, BY CHIP SEQUENCING, 2021-2026 (IN $ MILLION)
  • FIGURE 34: UNITED STATES NGS MARKET, BY DE NOVO SEQUENCING, 2021-2026 (IN $ MILLION)
  • FIGURE 35: UNITED STATES NGS MARKET, BY METHYL SEQUENCING, 2021-2026 (IN $ MILLION)
  • FIGURE 36: UNITED STATES INSTRUMENTS & CONSUMABLES MARKET, BY SANGER, 2021-2026 (IN $ MILLION)
  • FIGURE 37: UNITED STATES DNA SEQUENCING MARKET, BY SEQUENCING SERVICES, 2021-2026 (IN $ MILLION)
  • FIGURE 38: UNITED STATES DNA SEQUENCING MARKET, BY BIOINFORMATICS, 2021-2026 (IN $ MILLION)
  • FIGURE 39: UNITED STATES DNA SEQUENCING MARKET, BY END-USER, IN 2020
  • FIGURE 40: UNITED STATES DNA SEQUENCING MARKET, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, 2021-2026 (IN $ MILLION)
  • FIGURE 41: UNITED STATES DNA SEQUENCING MARKET, BY PHARMACEUTICAL, 2021-2026 (IN $ MILLION)
  • FIGURE 42: UNITED STATES DNA SEQUENCING MARKET, BY BIOTECHNOLOGY COMPANIES, 2021-2026 (IN $ MILLION)
  • FIGURE 43: UNITED STATES DNA SEQUENCING MARKET, BY HOSPITALS & CLINICS, 2021-2026 (IN $ MILLION)
  • FIGURE 44: UNITED STATES DNA SEQUENCING MARKET, BY OTHER END-USERS, 2021-2026 (IN $ MILLION)